Guidelines for occupational asthma;Normativa del asma ocupacional

Archivos de Bronconeumologia

Volumn 42, Issue 9, 2006, Pages 457-474

  Orriols Martínez, Ramon ^a   Abu Shams, Khalil ^b   Alday Figueroa, Enrique ^c   Cruz Carmona, María Jesús ^a   Bautista Galdiz Iturri, Juan ^d   Montes, Isabel Isidro ^e   Muñoz Gall, Xavier ^a   Quirce Gancedo, Santiago ^f   Sastre Domínguez, Joaquín ^f  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Universidad Pública de Navarra   (Spain)

^c Instituto Nacional de Seguridad e Higiene en el Trabajo   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; CYANOACRYLATE; DICHROMATE POTASSIUM; ETHANOLAMINE; GLUTARALDEHYDE; METHACRYLIC ACID METHYL ESTER; PENICILLIN G; POLYETHYLENE; POLYPROPYLENE; SPIRAMYCIN; TETRACYCLINE; TOSYLCHLORAMIDE SODIUM;

DISEASE CLASSIFICATION; HUMAN; MEDICOLEGAL ASPECT; MORBIDITY; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PHYSICAL EXAMINATION; PREVALENCE; PROGNOSIS; RESPIRATORY FUNCTION; REVIEW; THORAX RADIOGRAPHY;

EID: 33750293622     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13092417     Document Type: Article

References (145)

1. Bernstein IL, Bernstein DI, Chan-Yeung M, Malo JL. Definition and classification of asthma. En: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, editors. Asthma in the workplace. New York: Marcel Dekker; 1999. p. 1-3.
2. American Thoracic Society. Guidelines for assessing and managing asthma risk at work, school, and recreation. Am J Respir Crit Care Med. 2004;169:873-81.
3. Vandenplas O, Malo JL. Definitions and types of work-related asthma: a nosological approach. Eur Respir J. 2003;21:706-12.
4. Mapp CE, Boschetto P, Maestrelli P, Fabri LM. Occupational asthma. Am J Respir Crit Care Med. 2005;172:280-305.
5. Tarlo SM. Workplace irritant exposures: do they produce true occupational asthma? Ann Allergy Asthma Immunol. 2003;90 Suppl: 19-23.
6. Chang-Yeung M, Lam S. Occupational asthma. Am Rev Respir Dis. 1986;133:686-703.
7. Bernstein DI. Occupational asthma caused by exposure to low-molecular-weight chemicals. Immunol Allergy Clin North Am. 2003;23:221-34.
8. Gautrin D, Bernstein IL, Brooks S. Reactive airways dysfunction syndrome or irritant induced asthma. En: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, editors. Asthma in the workplace. New York: Marcel Dekker; 1999. p. 565-93.
9. Chan-Yeung M, Malo JL. Tables of major inducers of occupational asthma. En: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, editors. Asthma in the workplace. New York: Marcel Dekker; 1999. p. 683-720.
10. Bernstein DI. Allergic reactions to workplace allergens. JAMA. 1997;278:1907-13.
11. Cullinan P, Newman Taylor AJ. Aetiology of occupational asthma. Clin Exp Allergy. 1997;27:41-6.
12. Van Kampen V, Merget R, Baur X. Occupational airway sensitizers: an overview on the respective literature. Am J Ind Med. 2000;38:164-218.
13. Mapp CE. Agents, old and new, causing occupational asthma. Occup Environ Med. 2001;58:354-60.
14. Disponible en: www.worldallergy.org/professional/allergicdiseasecenter/ occupationalallergens/index.shtml
15. Disponible en: www.asmanet.com
16. Disponible en: www.asthme.csst.qc.ca
17. Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp CE, et al. American Thoracic Society statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med. 2003;167:787-97.
18. Tilles SA, Jerath-Tatum A. Differential diagnosis of occupational asthma. Immunol Allergy Clin N Am. 2003;23:167-76.
19. Contreras GR, Rousseau R, Chang-Yeung M. Occupational respiratory diseases in British Columbia, Canada in 1991. Occup Environ Med. 1994;51:710-2.
20. Kopferschmitt-Kubler MC, Ameille J, Popin E, Calastreng-Crinquand A, Vervloet D, Bayeux-Dunglas MC, et al. Occupational asthma in France: a 1-yr report of the Obsservatoire National de Asthmes Professioneis projet. Eur Respir J. 2002;19:84-9.
21. Muñoz X, Cruz MJ, Orriols R, Bravo C, Espuga M, Morell F. Occupational asthma due to persulfate salts. Diagnosis and follow-up. Chest. 2003;123:2124-9.
22. Orriols R, Costa R, Albanell M, Alberti C, Castejón J, Monsó E, et al. Reported occupational respiratory disease in Catalonia. Occup Environ Med. En prensa 2006.
23. Brooks SM, Weiss MR, Bernstein IL. Reactive airways dysfunction syndrome (RADS): persistent asthma syndrome after high level irritant exposures. Chest. 1985;88:376-84.
24. Tarlo SM, Broder I. Irritant-induced occupational asthma. Chest. 1989;96:297-301.
25. Bardana EJ. Reactive airway dysfunction syndrome (RADS): fact or fantasy. Allergy. 1999;54:33-5.
26. Costa R, Muñoz X, Avilés B, Drobnic ME, Orriols R. Síndrome de disfunción reactiva de las vías respiratorias. Estudio de 18 casos. Med Clin (Barc). 2005;11:419-26.
27. Matte TD, Hoffman RE, Rosenman KD, Stanbury M. Surveillance of occupational asthma under the SENSOR model. Chest. 1990;98:173S-8S.
28. McDonald JC, Keynes HL, Meredith SK. Reported incidence of occupational asthma in the United Kingdom 1989-1997. Occup Environ Med. 2000;57:823-9.
29. Tarlo SM. Workplace respiratory irritants and asthma. Occup Med. 2000;15:471-84.
30. Meredith SK, Taylor VM, McDonald JC. Occupational respiratory disease in the United Kingdom 1989: a report of the British Thoracic Society and the Society of Occupational Medicine by the SWORD project group. Br J Ind Med. 1991;48:292-8.
31. Venables KM, Hawkins ER, Tee RD, Longbottom JL, Newman-Taylor AJ. Smoking, atopy and laboratory animal allergy. Br J Ind Med. 1988;45:667-71.
32. Fish JE. Occupational asthma and rhinoconjuntivitis induced by natural rubber latex exposure. J Allergy Clin Immunol. 2002;110:575-81.
33. Mapp CE, Beghe B, Balboni A, Zamorani G, Padoan M, Jovine L, et al. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin Exp Allergy. 2000;30:651-6.
34. Home C, Quintana PJ, Keuwn PA, Dimich-Ward H, Chang-Yeung M. Distribution of DRB1 and DQB1 HLA class alleles in occupational asthma due to western re cedar. Eur Respir J. 2000;15:911-4.
35. Newman-Taylor AJ. HLA phenotype and exposure in development of occupation asthma. Ann Allergy Asthma Immunol. 2003;90 Suppl 2:24-7.
36. Sastre J, Vandesplas O, Park H-S. Pathogenesis of occupational asthma. Eur Respir J. 2003;22:364-7.
37. Wan H, Winton HL, Soeller C, Tovey ER, Gruenert DC, Thompson PJ, et al. Der pi facilitates transepithelial allergen delivery by disruption of tight functions. J Clin Invest. 1999;104:123-33.
38. Agius RM, Nee J, Mc Govern B, Robertson A. Structure activity hypotheses in occupational asthma caused by low molecular weight substances. Ann Occup Hyg. 1991;35:129-37.
39. Newman-Taylor A. Asthma and work: the Colt Lecture, delivered at the Ninth International Symposium on Inhaled Particles, Cambridge, September 2001. Ann Occup Hyg. 2002;46:563-74.
40. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med. 1995;333:107-12.
41. Venables KM, Topping MD, Howe W, Luczynska CM, Hawking R, Newman-Taylor AJ. Interactions of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. BMJ. 1985;290:201-4.
42. Biagini RE, Moorman WJ, Lewis TR, Bernstein IL. Ozone enhancement of platinum asthma in a primate model. Am Rev Respir Dis. 1986;134:719-25.
43. Park HS, Hong CS. The significance of specific IgG and IgG4 antibodies to a reactive dye in exposed workers. Clin Exp Allergy. 1991;21:357-62.
44. Maestrelli P, Saetta M, Mapp C, Fabri LM. Mechanisms of occupational asthma. Clin Exp Allergy. 1997;27 Suppl 1:47-54.
45. Maestrelli P, Del Prete GF, De Carli M, D'Elios MM, Saetta M, Di Stefano A, et al. CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scan J Work Environ Health. 1994;20:376-81.
46. Saetta M, Di Stefano A, Maestrelli P, De Marzo N, Milani GF, Pivirotto F, et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1992;145:160-8.
47. Frew AJ, Chan H, Lam S, Chan-Yeung M. Bronchial inflammation in asthma due to western red cedar. Am J Respir Crit Care Med. 1995;151:340-4.
48. Day BW, Jin R, Basalyga DM, Kramarik JA, Karol MH, et al. Formation, solvolysis and transcarbamoylation reactions of bil (s-glutathionyl) adducts of 2,4- and 2,6-diisocyanotoluene. Chem Res Toxicol. 1997;10:424-31.
49. Elms J, Beckett PN, Griffin P, Curran AD. Mechanisms of isocyanate sensitization. An in vitro approach. Toxicol in Vitro. 2001;15:631-4.
50. Quirce S, Sastre J. Occupational asthma. Allergy. 1998;53:633-41.
51. Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C. Evidence based guidelines for the prevention, identification and management of occupational asthma. Occup Environ Med. 2005;62:290-9.
52. Chang-Yeung M, Malo JL. Natural history of occupational asthma. En: Chang-Yeung M, Bernstein IL, Malo JL, Bernstein DI, editors. Asthma in the workplace and related disorders. 2nd ed. New York: Marcel Dekker; 1999. p. 129-44.
53. Malo JL, Ghezzo M, L'Archevêgue J, Lagier F, Perrin B, Cartier A. Is the clinical history a satisfactory mean of diagnosis occupational asthma? Am Rev Respir Dis. 1991;143:528-32.
54. Gilbert R, Auchncloss JH. Post-test probability of asthma following methacholine challenge. Chest. 1990;97:562-5.
55. Mapp CE, Dal Vecchio L, Boschetto P, De Marzo N, Fabbri LM. Toluene diisocyanate-induced asthma without airway hyperresponsiveness. Eur Respir J. 1996;68:89-95.
56. Sastre J, Fernández-Nieto M, Novalbos A, De las Heras M, Cuesta J, Quirce S. Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge. Chest. 2003;123:1276-9.
57. Vandenplas O, Delwiche JP, Jamart J, Van de Weyer R. Increase in nonspecific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during inhalation challenges. Thorax. 1996;51:472-8.
58. Ruëf F, Thomas P, Reissig G, Przybilla B. Natural rubber-latex allergy in patients not intensely exposed. Allergy. 1998;53:445-9.
59. Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol. 1998;101:709-15.
60. Burge S, Moscato G. Physiological assessment: serial measurements of lung function. En: Bernstein IL, Chang-Yeung M, Malo JL, et al, editors. Asthma in the workplace. New York: Marcel Dekker; 1993. p. 193-210.
61. Leroyer C, Perfetti L, Trudeau C, L'Archevêque, Chang-Yeung M, Malo JL. Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma. Am J Respir Crit Care Med. 1998;158:827-32.
62. Perrin B, Lagier F, L'Archeveque J, Cartier A, Boulet LP, Cote J, et al. Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur Respir J. 1992;5:40-8.
63. Anees W, Gannon PF, Huggins V, Pantin CF, Burge PS. Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma. Eur Respir J. 2004;23:730-4.
64. Gannon PFG, Newton DT, Belcher J, Pantin CF, Burge PS. Development of OASYS-2: a system for the analysis of serial measurement of peak expiratory flow in workers with suspected occupational asthma. Thorax. 1996;51:484-9.
65. Cartier A, Malo JL. Occupational challenge tests. En: Bernstein IL, Chang-Yeung M, Malo JL, et al, editors. Asthma in the workplace. New York: Marcel Dekker; 1993. p. 211-33.
66. Sastre J, Quirce S, Novalbos A, Lluch M, Bombin C, Umpierrez A. Occupational asthma induced by cephalosporins. Eur Respir J. 1999;13:1189-91.
67. Hammad YY, Rando RJ, Abdel-Kader H. Considerations in the design and use of human inhalation challenge delivery systems. Folia Allergol Immunol Clin. 1985;32:37-44.
68. Vandesplas O, Malo JL, Cartier A, Perreault G, Cloutier Y. Closed-circuit methodology for inhalation challenge test with isocianates. Am Rev Respir Dis. 1992;145:582-7.
69. Orriols R, Drobnic S, Muñoz X, Rodrigo MJ, Morell F. Asma ocupacional por isocianatos: estudio de 21 pacientes. Med Clin (Barc). 1999;113:659-62.
70. Taivainen AI, Tukiainen HO, Terho EO, Husman KR. Powered dust respirator helmets in the prevention of occupational asthma among farmers. Scand J Work Environ Health. 1998;24:503-7.
71. Obase Y, Shimoda T, Mitsuta K, Matsuse H, Cono S. Two patients with occupational asthma who returned to work with dust respirators. Occup Environ Med. 2000;57:62-4.
72. Marabini A, Siracusa A, Stopponni R, Tacconi C, Abbritti G. Outcome of occupational asthma in patients with continuous exposure: a 3 year longitudinal study during pharmacologic treatment. Chest. 2003;124:2372-6.
73. Dewitte JD, Chan-Yeung M, Malo JL. Medicolegal and compensation aspects of occupational asthma. Eur Respir J. 1994;7:969-80.
74. Vandesplas O, Toren K, Blanc PD. Health and socioeconomic impact of work-related asthma. Eur Respir J. 2003;22:689-97.
75. Chan-Yeung M. Assessment of asthma in the workplace. ACCP consensus statement. American College of Chest Physicians. Chest. 1995;108:1084-117.
76. Lemière C, Malo J-L, Boulet L. Reactive airways dysfunction syndrome due to chlorine: sequential bronchial biopsies and functional assessment. Eur Respir J. 1997;10:241-4.
77. Chester E, Kaimal J, Payne CB Jr, Kohn PM. Pulmonary injury following exposure to chlorine gas. Possible beneficial effects of steroid treatment. Chest. 1977;72:247-50.
78. Chan-Yeung M, Lam S, Kennedy SM, Frew A. Persistent asthma after repeated exposure to high concentrations of gases in pulmills. Am J Respir Crit Care Med. 1994;149:1676-80.
79. Bherer L, Cushman R, Courteau JP, Quevillon M, Cote G, Bourbeau J, et al. Survey of construction workers repeatedly exposed to chlorine over a three to six month period in a pulpmill: II. Follow up to affected workers by questionnaire, spirometry, and assessment of bronchial responsiveness 18 to 24 months after exposure ended. Occup Environ Med. 1994;51:225-8.
80. Gautrin D, Leroyer C, Infante-Rivard C, Ghezzo H, Dufour JG, Girard D, et al. Longitudinal assessment of airway caliber and responsiveness in workers exposed to chlorine. Am J Respir Crit Care Med. 1999;160:1232-7.
81. Blanc PD, Galbo M, Hiatt P, Olson KR. Morbidity following acute irritant inhalation in a population based study. JAMA. 1991;266:664-9.
82. Niven RMI, Pickering CAC. Byssinosis: a review. Thorax. 1996;51:632-7.
83. Pickering CAC. Byssinosis. En: Hendrick DJ, Sherwood Burge P, Beckett WS, Churg A, editors. Occupational disorders of the lung: recognition, management and prevention. Edinburgh: Saunders; 2002. p. 46-7.
84. Fishwick D, Fletcher AM, Pickering CAC, Niven RML, Faragher EB. Lung function, bronchial reactivity, atopic status and dust exposure in Lancashire mill operatives. Am Rev Respir Dis. 1992;145:1103-8.
85. Glindmeyer HW, Lefante JJ, Jones RN, Rando RJ, Weill H. Cotton dust and across-shift change in FEV1, as predictors of annual change in FEV1. Am J Respir Crit Care Med. 1994;149:584-90.
86. Christiani DC, Wang X-R, Pan L-D, Zhang H-X, Sun B-X, Dai H, et al. Longitudinal changes in pulmonary function and respiratory symptoms in cotton textile workers. A 15-year follow-up study. Am J Respir Crit Care Med. 2001;163:847-53.
87. WHO. Recommended health-based occupational exposure limits for selected vegetables dust Report of a WHO study group. Technical Report Series 684. Geneva: WHO; 1983.
88. Chan-Yeung M, Emerson DA, Kennedy SM. The impact of grain dust on respiratory health. Am Rev Respir Dis. 1992;145:476-87.
89. Magarolas R, Monsó E, Aguilar X, Radon K, Nowak D, Martínez C, et al. Prevalencia y factures de riesgo de síntomas respiratorios en la agricultura y la ganadería. Med Clin (Barc). 2000;114:685-9.
90. Borghetti C, Magarolas R, Badorrey I, Radon K, Morera J, Monsó E. Sensibilización y asma ocupacional en los avicultores. Med Clin (Barc). 2002;118:251-5.
91. Eduard W, Douwes J, Omenaas E, Heederick D. Do farming exposures cause or prevent asthma? Results from a study of adult Norwegian farmers. Thorax. 2004;59:381-6.
92. Soyseth V, Kongerud J, Ekstrand J, Boe J. Relation between exposure to fluoride and bronchial responsiveness in aluminium potroom workers with work-related asthma-like symptoms. Thorax. 1994;49:984-9.
93. Tarlo SM, Leung K, Broder I, Silverman F, Holness DL. Asthmatic subjects symptomatically worse at work: prevalence and characterization among a general asthma clinic population. Chest. 2000;118:1309-14.
94. Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implication for treatment. Thorax. 2002;57:178-82.
95. Quirce S. Eosinophilic bronchitis in the workplace. Curr Opin Allergy Clin Immunol. 2004;4:87-91.
96. Quirce S, Fernández-Nieto M, De Miguel J, Sastre J. Chronic cough due to latex-induced eosinophilic bronchitis. J Allergy Clin Immunol. 2001;108:143.
97. Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med. 2003;168:1277-92.
98. Orriols R, Bravo C. Bronquiolitis obliterante: dificultades de la definición. Arch Bronconeumol. 1995;31:1-2.
99. Kreiss K, Gomaa A, Kullman G, Fedan K, Simoes EJ, Enright PL. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med. 2002;347:330-8.
100. Boag AH, Colby TV, Fraire AE, Kuhn C, Roggli VL, Travis WD. The pathology of interstitial lung disease in nylon flock workers. Am J Surg Pathol. 1999;23:1539-45.
101. Orriols R, Manresa JM, Aliaga JLL, Codina R, Rodrigo MJ, Morell F. Mollusk shell hypersensitivity pneumonitis. Ann Intern Med. 1990;113:80-1.
102. Morell F, Roger A, Cruz MJ, Muñoz X, Rodrigo MJ. Suberosis. Clinical study and new etiologic agents in a series of eight patients. Chest. 2003;124:1145-52.
103. Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol. 2001;108:661-70.
104. Orriols R, Aliaga JLL, Antó JM, Ferrer A, Hernández A, Rodrigo MJ, et al. High prevalence of mollusc shell hypersensitivity pneumonitis in nacre factory workers. Eur Respir J. 1997;10:780-6.
105. Lacasse Y, Selman M, Costabel U, Dalphin J, Ando M, Morell F, et al. Clinical diagnosis of hypersensitivity pneumonias. Am J Respir Crit Care Med. 2003;168:952-8.
106. Newman KB, Mason UG, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med. 1995;152:1382-6.
107. Perkner JJ, Fennelly KP, Balkissoon R, Bartelson BB, Ruttenber AJ, Wood RP, et al. Irritant-associated vocal cord dysfunction. J Occup Environ Med. 1998;40:136-43.
108. Cullen MR. The worker with multiple chemical sensitivities: an overview. Occup Med. 1987;2:655-61.
109. Lesage J, Perrault G. Environmental monitoring of chemical agents. En: Bernstein IL, Chan-Yeung M, Malo J-L, Bernstein DI, editors. Asthma in the workplace. New York: Marcel Deckker; 1999. p. 257-77.
110. Disponible en: www.mtas.es/insht/mta
111. Disponible en: www.cdc.gov/niosh/nmam/nmammenu.html
112. Disponible en: www.osha.gov/dts/sltc/methods/index.html
113. Instituto Nacional de Seguridad e Higiene en el Trabajo. Límites de exposición profesional para agentes químicos en España. Madrid: Ministerio de Trabajo y Asuntos Sociales. Instituto Nacional de Seguridad e Higiene en el Trabajo; 2003.
114. Reed CE, Swanson MC, Li JT. Environmental monitoring of protein aeroallergens. En: Bernstein IL, Chang-Yeung M, Malo JL, Bernstein DJ, editors. Asthma in the workplace. 2nd ed. New York: Marcel Dekker Inc.; 1999. p. 235-55.
115. Price JA, Pollock I, Little SA, Longbottom JL, Warner JO. Measurement of airborne mite antigen in homes of asthmatic children. Lancet. 1990;336:895-7.
116. Luczynska CM, Li Y, Chapman MD, Platts-Mills TAE. Airborne concentrations and particle size distribution of allergen derived from domestic cat (Felis domesticus). Am Rev Resp Dis. 1990;141:361-7.
117. Price JA, Longbottom JL. ELISA method for the measurement of airborne levels of major laboratory animal allergens. Clin Allergy. 1988;18:95-107.
118. Lillienberg L, Baur X, Doekes G, Belin L, Raulf-Heimsoth M, Sander I, et al. Comparison of four methods to assess fungal amylase in flour dust. Ann Occup Hyg. 2000;44:427-33.
119. Raulf-Heimsoth M, Sander I, Chez Z, Borowitzki G, Diewald K, Van Kampen V, et al. Development of a monoclonal antibody-based sandwich ELISA for detection of the latex allergen Hev b 1. Int Arch Allergy Immunol. 2000;123:236-41.
120. Zahradnik E, Raulf-Heimsoth M, Brüning T, Doekes G, Sander I. Development of a sandwich enzyme immunoassay for quantification of phytase derived from Aspergillus niger [resumen]. Actas del Exposure Assessment in a Changing Environment Congress; 2004; p. 49. 28-5. Utrecht, The Netherlands, June 2004.
121. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Antibody detection and preparation. En: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current protocols in immunology. New York: John Wiley & Sons Inc.; 1997.
122. Renström A, Gordon S, Hollander A, Spithoven J, Larsson PH, Venables KM, et al. Comparison of methods to assess airborne rat and mouse allergen levels II. Factors influencing antigen detection. Allergy. 1999;54:150-7.
123. Renström A, Gordon S, Larsson PH, Tee RD, Newman-Taylor AJ, Malmberg P. Comparison of a radioallergosorbent (RAST) inhibition method and a monoclonal enzyme-linked immunosorbent assay (ELISA) for aeroallergen measurement. Clin Exp Allergy. 1997;27:1314-21.
124. Cruz MJ, Rodrigo MJ, Antó JM, Morell F. An amplified ELISA-inhibition method for the measurement of airborne soybean allergens. Int Arch Allergy Clin Immunol. 2000;122:42-8.
125. Platts-Mills TA, Sporik RB, Wheatley LM, Heymann PW. Is there a dose-response relationship between exposure to indoor allergens and symptoms of asthma? J Allergy Clin Immunol. 1995;96:435-40.
126. Baur X. Are we closer to developing threshold limit values for allergens in the workplace? Ann Allergy Asthma Immunol. 2003;90 Suppl:11-8.
127. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Resp Crit Care Med. 1996;154:308-17.
128. Lemière C, Pizzichini MM, Balkissoon R, Clelland L, Efthimiadis A, O'Sy D, et al. Diagnosing occupational asthma: use of induced sputum. Eur Respir J. 1999;13:482-8.
129. Girard F, Chaboilliez S, Cartier A, Coté J, Hargreave F, Labrecque M, et al. An effective strategy for diagnosing occupational asthma. Am J Respir Crit Care Med. 2004;170:845-50.
130. Lemière C, Chaboilliez S, Malo JL, Cartier A. Changes in sputum cell counts after exposure to occupational agents: What do they mean? J Allergy Clin Immunol. 2001;107:1063-8.
131. Lemière C. Non-invasive assessment of airway inflamation in occupational lung diseases. Curr Opin Allergy Clin Immunol. 2002;2:109-14.
132. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recomendations. The European Respiratory Society Task Force. Eur Respir J. 1997;10:1683-93.
133. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med. 1999;160:2104-17.
134. Kharitonov S, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001;163:1693-722.
135. Campo P, Lummus ZL, Bernstein D. Advances in methods used in evaluation of occupational asthma. Curr Opin Pulm Med. 2004;10:142-6.
136. Montuschi P, Barnes P. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci. 2002;23:232-7.
137. Hunt J. Exhaled breath condensate: an envolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol. 2002;110:28-34.
138. Bernstein IL, Keskiene H, Malo J-L. Medicolegal and compensation aspects. En: Bersntein IL, Chang-Yeung M, Malo JL, Bernstein DJ, editors. Ashtma in the workplace. New York: Marcel Dekker; 1999. p. 279-97.
139. Disponible en: www.mtas.es/insh/ntp/ntp-327.htm
140. Cuadro de enfermedades profesionales. Real Decreto 1995/1978 del 12 de mayo. BOE núm. 25, de agosto de 1978.
141. Disponible en: www.mcs.es/Diseno/medioAmbient_salud_laboral.htm
142. WHO. International classification of impairment, disabilities and handicap. Geneva: WHO; 1980.
143. WHO. CIDDM-2. Clasificación internacional del funcionamiento de la discapacidad y de la salud. 2001. Disponible en: www.who.cn/icidh
144. Disponible en: www.mtas.es/guia2003/texto/30/30.6.html
145. American Thoracic Society (ATS). Guidelines for the evaluation of impairment/disability in patients with asthma. Am Rev Respir Dis. 1993;147:1056-61.